“Robust clinical trials methods are the spine of credible analysis and a vital pillar of Ghana’s vaccine manufacturing time table.”

This message from Dr Fiona Braka, Global Well being Group (WHO) Consultant to Ghana, set the tone for a high-level accumulating of policymakers, regulators, and researchers in Sogakope within the Volta Area, at a second when Ghana is taking planned steps to transition from vaccine dependency to self-reliance.

The urgency of this shift is rooted within the onerous courses of the COVID-19 pandemic, which uncovered stark world inequities in get admission to to life-saving vaccines. For Ghana, delays in securing doses underscored a vital vulnerability: reliance on exterior provide in instances of worldwide disaster. These days, the rustic’s push towards native vaccine and pharmaceutical manufacturing is not just a strategic precedence, but in addition a need for shielding public well being and strengthening nationwide resilience.

However manufacturing by myself can’t ensure have an effect on. A well-coordinated clinical trials machine, anchored in robust regulatory oversight, moral integrity, and institutional capability, promises secure and, efficacious vaccines produced in the neighborhood in addition to the worldwide credibility required to serve each nationwide and regional wishes.

To reinforce this very important element of Ghana’s vaccine time table, WHO in collaboration with the Nationwide Vaccine Institute (NVI), hosted a three-day Clinical Trials Overview Workshop from 30 March to at least one April 2026 in Sogakope. Supported by way of the Eu Union beneath the Vax & Pharm Ghana Challenge. The workshop convened key establishments to guage Ghana’s clinical trials panorama and align it with world requirements.

Members from the Meals and Medication Authority, Ghana Well being Carrier, ethics committees, academia, and clinical analysis establishments engaged in a structured programme that moved from figuring out world requirements to making use of them inside of Ghana’s context. Discussions started with an summary of the present clinical trials atmosphere, highlighting each growth and protracted gaps in clinical analysis coordination, ethics overview, and operational potency.

Opening the workshop, Dr Sodzi-Sodzi Tettey, CEO of the Nationwide Vaccine Institute emphasised the significance of the initiative. 
“Ghana’s ambition to fabricate vaccines and prescription drugs can’t be learned with out a credible and environment friendly clinical trials ecosystem. This workshop is a key step towards development the methods, partnerships, and requirements required to toughen that imaginative and prescient”, he mentioned.

Over the 3 days, technical professionals presented WHO steerage on Excellent Clinical Follow, moral ideas, and regulatory oversight, whilst additionally sharing courses from around the African area and past. Members explored sensible equipment for strengthening ethics oversight and risk-based tracking and labored collaboratively to map stakeholders and establish bottlenecks affecting the behavior of clinical trials..

A big milestone used to be the creation of the draft WHO Clinical Trials Ecosystem Overview Instrument. Thru team paintings, individuals started adapting the device to Ghana’s wishes and advanced a harmonized box evaluate plan, outlining how establishments, timelines, and evaluate groups will toughen a national analysis of clinical trial capability.

The WHO Consultant to Ghana reiterated the wider importance of the initiative:
“WHO will proceed to toughen Ghana with the technical experience and coordination had to construct a machine that meets world requirements and serves nationwide priorities.”

The Eu Union used to be said for its toughen in making the workshop conceivable.

A consultant of the Eu Union mentioned, 
“Our toughen to the Vax & Pharm Ghana Challenge displays a shared dedication to strengthening native capability. A strong clinical trials ecosystem guarantees that Ghana’s inventions don’t seem to be best in the neighborhood produced, however globally known”. 

Via the tip of the 3 days, stakeholders had advanced a draft nationwide motion plan to reinforce clinical trials governance and operations, marking crucial step towards a extra coordinated and efficient machine.

As Ghana continues to place itself as a hub for vaccine and pharmaceutical manufacturing, investments in clinical trials methods will stay very important, making sure that medical growth interprets into secure, relied on, and out there well being answers for all.